KLAC:NASDAQKLA Corporation Analysis
Data as of 2026-09-07 - not real-time
$185.60
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind KLA Corporation is neutral at $185.60, with no clear ordering between short and long averages. Over a rolling month the price has lost 11.8%. Relative strength is 47.4 — neutral — and the MACD signal is bullish. The recent range runs from support at $167.05 up to resistance at $214.80.
Valuation screens as overvalued: a P/E of 50.7 sits above the sector average of 33.2. Consensus targets land 26.0% above where the shares trade now. Revenue is growing at 15.2% on a 35.6% profit margin. The 0.50% dividend yield looks covered by current payout levels.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 61.9%, a beta of 2.81 and a maximum drawdown of 43.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Valuation screens as overvalued: a P/E of 50.7 sits above the sector average of 33.2. Consensus targets land 26.0% above where the shares trade now. Revenue is growing at 15.2% on a 35.6% profit margin. The 0.50% dividend yield looks covered by current payout levels.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 61.9%, a beta of 2.81 and a maximum drawdown of 43.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
KLA Corporation recently declared a quarterly cash dividend of US$0.Semiconductor manufacturing equipment maker KLA Corporation NASDAQ:KLAC reported Q2 CY2026 results , with sales up 15.KLA Corp KLAC achieves record revenue of $3.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 171.52
- MACD momentum is positive
- 30-day price change of -11.8%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 50.7 versus sector average of 33.2
- Trading above the 200-day average of 171.52
- Analyst targets imply +26.0% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 50.7 versus sector average of 33.2
- Analyst targets imply +26.0% versus the current price
- Profit margin of 35.6% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth15.20%
Profit Margin35.57%
P/E Ratio50.7
ROE87.50%
ROA20.80%
Debt/Equity96.88
P/B Ratio38.2
Op. Cash Flow$4.1B
Free Cash Flow$2.6B
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI47.4
Support$167.05
Resistance$214.80
MA 20$187.87
MA 50$205.76
MA 200$171.52
MACDBullish
VolumeDecreasing
Fear & Greed Index94.11
Valuation
Fair Value$46.74
Target Price$233.77
Upside/Downside25.95%
GradeOvervalued
TypeGrowth
Dividend Yield0.50%
Risk Assessment
Beta2.81
Volatility61.94%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.